Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Cancer × Sorafenib × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 33 Liver Neoplasms 18 Neoplasms 13 Neoplasm Metastasis 11 Leukemia, Myeloid, Acute 11 Carcinoma, Renal Cell 8 Pancreatic Neoplasms 7 Melanoma 7 Carcinoma, Non-Small-Cell Lung 7 Breast Neoplasms 6 Brain Neoplasms 6 Unspecified Adult Solid Tumor, Protocol Specific 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 5 Recurrence 4 Prostatic Neoplasms 4 Lung Neoplasms 4 Kidney Neoplasms 4 Glioblastoma 4 Sarcoma 3 Rectal Neoplasms 3 Myelodysplastic Syndromes 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Solid Tumors 2 Neuroblastoma 2 Myelodysplastic-Myeloproliferative Diseases 2

Interventions

Nivolumab 6 Bevacizumab 5 temsirolimus 4 Sirolimus 4 Paclitaxel 4 Docetaxel 4 Pemetrexed 3 Ipilimumab 3 Erlotinib Hydrochloride 3 Carboplatin 3 apatinib 2 abemaciclib 2 Vorinostat 2 Magnetic Resonance Spectroscopy 2 Gemcitabine 2 Everolimus 2 Chlorogenic Acid 2 Cetuximab 2 ARRY-334543 2 6-(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-ylsulfanyl)quinoline 2 vorolanib 1 vistusertib 1 trametinib 1 tislelizumab 1 tilsotolimod 1 sargramostim 1 regorafenib 1 ralimetinib 1 pazopanib 1 palifosfamide lysine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00543504 2020-06-30

Bevacizumab in Multiple Phase I Combinations

M.D. Anderson Cancer Center

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡